Target intelligence / Profile preview

Collagen synthesis machinery

Molecular classification
Enzyme, Chaperone, Other
01

Overview

The collagen synthesis machinery is a complex, multi-step biological system responsible for the production, modification, and extracellular assembly of collagen, the most abundant protein in the human body (Gelse et al., 2003). This machinery includes intracellular enzymes such as prolyl 4-hydroxylase and lysyl hydroxylase, which perform critical post-translational modifications, and the molecular chaperone HSP47, which ensures proper triple-helix folding in the endoplasmic reticulum (Ito & Nagata, 2017). Following secretion, procollagen peptidases remove terminal peptides, and lysyl oxidase (LOX) catalyzes the cross-linking of collagen molecules into stable, insoluble fibrils (Rodriguez et al., 2008). In pathological states like systemic sclerosis, pulmonary fibrosis, and cirrhosis, this machinery becomes overactive, leading to excessive extracellular matrix deposition and organ failure (Wynn, 2008). Pharmacological targeting of this machinery involves inhibiting specific enzymatic steps or chaperones to reduce collagen accumulation, though such interventions must balance efficacy with the risk of disrupting normal tissue maintenance and wound repair (Ricard-Blum, 2011).

Other names
Collagen biosynthetic pathwayProcollagen processing machineryCollagen assembly complex
02

Mechanism of action

Inhibition of post-translational modifications (hydroxylation), molecular chaperone-mediated folding (HSP47), or extracellular cross-linking (LOX) to prevent the formation of mature, pathological collagen fibrils.

03

Biological functions

Extracellular matrix organizationProtein foldingProtein hydroxylationProtein glycosylationCross-linkingOther
04

Disease associations

FibrosisCancerSclerodermaOsteogenesis imperfectaEhlers-Danlos syndromeOther
05

Safety considerations

Impaired wound healingBone fragilityVascular instabilityConnective tissue disorders
06

Interacting drugs

Pirfenidone

4 more in the full profile.

07

Biomarkers

Pro-collagen III N-terminal peptide (PIIINP)Pro-C3 (collagen type III synthesis marker)HydroxyprolineC-terminal telopeptide of type I collagen (CTX-I)

Beyond the preview

Go deeper on Collagen synthesis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen synthesis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call